ALC:NYSE
Alcon AG
74,31 $
arrow_downward
−0,26%(−0,19) 1D
74,31 $
0,00% (0,00)
bedtimePo zaprtju
Zaprto: 20. nov., 16:00:05 GMT -5 · USD
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za ALC …
Odpri
74,16 $
Visoka
75,04 $
Nizka
74,10 $
Tržna kapitalizacija
31,15 mrd.
Povprečni promet
2,43 mio.
Promet
3,42 mio.
52-tedenski najvišji tečaj
87,64 $
52-tedenski najnižji tečaj
61,84 $
Beta
0,87
Št. izdanih delnic
480,40 mio.
Št. zaposlenih
25 tis.
Odpri
74,16 $
Visoka
75,04 $
Nizka
74,10 $
Tržna kapitalizacija
31,15 mrd.
Povprečni promet
2,43 mio.
Promet
3,42 mio.
52-tedenski najvišji tečaj
87,64 $
52-tedenski najnižji tečaj
61,84 $
Beta
0,87
Št. izdanih delnic
480,40 mio.
Št. zaposlenih
25 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
Yahoo Finance
·
pred 7 urami
Bill Ackman Opened About $2 Billion in New Positions in Alcon and Intercontinental Exchange
ad-hoc-news.de
·
pred 1 dnevom
Alcon stock: Pershing Square takes a $954 million stake
TradingView
·
pred 1 dnevom
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Vizitka: Alcon AG
Generalni direktorDavid J. Endicott
Št. zaposlenih25 tis.
Ustanovljeno1945
SedežŽeneva, Ženeva, Švica
SektorHealth Care
Panoga-
Spletno mestoalcon.com